nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—Alzheimer's disease	0.465	1	CbGaD
Cinitapride—HTR2A—Donepezil—Alzheimer's disease	0.378	1	CbGbCtD
Cinitapride—HTR2A—choroid plexus—Alzheimer's disease	0.0158	0.205	CbGeAlD
Cinitapride—HTR4—telencephalon—Alzheimer's disease	0.0102	0.132	CbGeAlD
Cinitapride—HTR2A—locus ceruleus—Alzheimer's disease	0.00975	0.127	CbGeAlD
Cinitapride—HTR2A—cerebellar cortex—Alzheimer's disease	0.00795	0.103	CbGeAlD
Cinitapride—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00776	0.101	CbGeAlD
Cinitapride—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00462	0.0601	CbGeAlD
Cinitapride—HTR4—brain—Alzheimer's disease	0.0046	0.0598	CbGeAlD
Cinitapride—HTR2A—blood vessel—Alzheimer's disease	0.00229	0.0297	CbGeAlD
Cinitapride—HTR1A—forebrain—Alzheimer's disease	0.00203	0.0263	CbGeAlD
Cinitapride—HTR1A—telencephalon—Alzheimer's disease	0.00186	0.0242	CbGeAlD
Cinitapride—HTR2A—embryo—Alzheimer's disease	0.00136	0.0177	CbGeAlD
Cinitapride—HTR2A—forebrain—Alzheimer's disease	0.00121	0.0157	CbGeAlD
Cinitapride—HTR2A—telencephalon—Alzheimer's disease	0.00111	0.0144	CbGeAlD
Cinitapride—HTR1A—nervous system—Alzheimer's disease	0.0011	0.0143	CbGeAlD
Cinitapride—HTR1A—central nervous system—Alzheimer's disease	0.00106	0.0138	CbGeAlD
Cinitapride—HTR1A—cerebellum—Alzheimer's disease	0.00103	0.0135	CbGeAlD
Cinitapride—HTR1A—brain—Alzheimer's disease	0.00084	0.0109	CbGeAlD
Cinitapride—HTR2A—nervous system—Alzheimer's disease	0.000655	0.00852	CbGeAlD
Cinitapride—HTR2A—central nervous system—Alzheimer's disease	0.000631	0.0082	CbGeAlD
Cinitapride—HTR2A—cerebellum—Alzheimer's disease	0.000617	0.00802	CbGeAlD
Cinitapride—HTR2A—brain—Alzheimer's disease	0.000501	0.00651	CbGeAlD
Cinitapride—HTR4—Signaling Pathways—GSK3A—Alzheimer's disease	7.81e-05	0.000971	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CDK5—Alzheimer's disease	7.74e-05	0.000963	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PYY—Alzheimer's disease	7.71e-05	0.00096	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—APP—Alzheimer's disease	7.67e-05	0.000955	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—NPS—Alzheimer's disease	7.49e-05	0.000932	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR6—Alzheimer's disease	7.45e-05	0.000927	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—F2—Alzheimer's disease	7.37e-05	0.000917	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PLCB1—Alzheimer's disease	7.24e-05	0.000901	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—SST—Alzheimer's disease	7.14e-05	0.000889	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HTR6—Alzheimer's disease	7.09e-05	0.000882	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	7.08e-05	0.000881	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	7.07e-05	0.000879	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	7.05e-05	0.000878	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	7e-05	0.000871	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	7e-05	0.00087	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—APP—Alzheimer's disease	6.96e-05	0.000866	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	6.85e-05	0.000852	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GAL—Alzheimer's disease	6.82e-05	0.000848	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NGFR—Alzheimer's disease	6.76e-05	0.000841	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CREB1—Alzheimer's disease	6.71e-05	0.000835	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CDK5—Alzheimer's disease	6.69e-05	0.000832	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ADAM10—Alzheimer's disease	6.6e-05	0.000821	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CCL2—Alzheimer's disease	6.57e-05	0.000817	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HTR6—Alzheimer's disease	6.44e-05	0.000801	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	6.38e-05	0.000794	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—S100B—Alzheimer's disease	6.24e-05	0.000776	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GAL—Alzheimer's disease	6.19e-05	0.00077	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	6.12e-05	0.000761	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	6.1e-05	0.00076	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	6.04e-05	0.000752	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TTR—Alzheimer's disease	6.04e-05	0.000751	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	6e-05	0.000747	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	6e-05	0.000746	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF2—Alzheimer's disease	5.94e-05	0.000739	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GAL—Alzheimer's disease	5.89e-05	0.000733	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF1R—Alzheimer's disease	5.74e-05	0.000715	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—LPL—Alzheimer's disease	5.51e-05	0.000685	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MEF2C—Alzheimer's disease	5.46e-05	0.000679	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PRKCG—Alzheimer's disease	5.35e-05	0.000666	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—NPY—Alzheimer's disease	5.35e-05	0.000666	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	5.35e-05	0.000666	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GAL—Alzheimer's disease	5.35e-05	0.000665	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCR5—Alzheimer's disease	5.33e-05	0.000663	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IAPP—Alzheimer's disease	5.32e-05	0.000662	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PYY—Alzheimer's disease	5.28e-05	0.000656	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NGF—Alzheimer's disease	5.22e-05	0.000649	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TTR—Alzheimer's disease	5.21e-05	0.000649	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HTR2A—Alzheimer's disease	5.21e-05	0.000649	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	5.18e-05	0.000645	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	5.18e-05	0.000645	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CRH—Alzheimer's disease	5.17e-05	0.000643	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	5.14e-05	0.000639	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCR5—Alzheimer's disease	5.07e-05	0.000631	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HTR2A—Alzheimer's disease	4.97e-05	0.000618	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—NPS—Alzheimer's disease	4.9e-05	0.000609	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—NPY—Alzheimer's disease	4.86e-05	0.000605	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IAPP—Alzheimer's disease	4.83e-05	0.000601	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CRH—Alzheimer's disease	4.69e-05	0.000584	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GAB2—Alzheimer's disease	4.67e-05	0.000581	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—SST—Alzheimer's disease	4.67e-05	0.000581	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CALM1—Alzheimer's disease	4.63e-05	0.000576	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—NPY—Alzheimer's disease	4.63e-05	0.000576	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	4.62e-05	0.000575	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—LEP—Alzheimer's disease	4.62e-05	0.000574	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—APOE—Alzheimer's disease	4.62e-05	0.000574	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCR5—Alzheimer's disease	4.6e-05	0.000573	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IAPP—Alzheimer's disease	4.6e-05	0.000572	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CAV1—Alzheimer's disease	4.57e-05	0.000569	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDK5—Alzheimer's disease	4.57e-05	0.000569	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—F2—Alzheimer's disease	4.57e-05	0.000569	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PYY—Alzheimer's disease	4.56e-05	0.000567	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—APP—Alzheimer's disease	4.55e-05	0.000567	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CRH—Alzheimer's disease	4.46e-05	0.000555	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—NPS—Alzheimer's disease	4.45e-05	0.000553	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.44e-05	0.000552	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.42e-05	0.000551	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ESR1—Alzheimer's disease	4.41e-05	0.000548	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR6—Alzheimer's disease	4.4e-05	0.000548	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—F2—Alzheimer's disease	4.35e-05	0.000542	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.3e-05	0.000535	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOTCH1—Alzheimer's disease	4.26e-05	0.00053	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—SST—Alzheimer's disease	4.24e-05	0.000528	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GAB2—Alzheimer's disease	4.24e-05	0.000528	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—NPS—Alzheimer's disease	4.23e-05	0.000526	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NPY—Alzheimer's disease	4.2e-05	0.000523	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IAPP—Alzheimer's disease	4.17e-05	0.000519	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.15e-05	0.000516	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—APP—Alzheimer's disease	4.13e-05	0.000514	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL2—Alzheimer's disease	4.07e-05	0.000507	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CRH—Alzheimer's disease	4.05e-05	0.000504	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GAB2—Alzheimer's disease	4.04e-05	0.000502	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—SST—Alzheimer's disease	4.04e-05	0.000502	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PSENEN—Alzheimer's disease	4e-05	0.000497	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GSK3B—Alzheimer's disease	4e-05	0.000497	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CREB1—Alzheimer's disease	3.97e-05	0.000493	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDK5—Alzheimer's disease	3.95e-05	0.000492	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—F2—Alzheimer's disease	3.95e-05	0.000491	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—INS—Alzheimer's disease	3.94e-05	0.000491	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APH1A—Alzheimer's disease	3.94e-05	0.000491	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—APP—Alzheimer's disease	3.93e-05	0.000489	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	3.9e-05	0.000485	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL2—Alzheimer's disease	3.88e-05	0.000483	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NPS—Alzheimer's disease	3.84e-05	0.000478	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	3.84e-05	0.000478	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.82e-05	0.000476	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF1—Alzheimer's disease	3.81e-05	0.000475	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HTR6—Alzheimer's disease	3.8e-05	0.000473	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	3.74e-05	0.000466	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.71e-05	0.000462	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GAB2—Alzheimer's disease	3.67e-05	0.000456	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—SST—Alzheimer's disease	3.67e-05	0.000456	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	3.66e-05	0.000455	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	3.66e-05	0.000455	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.58e-05	0.000446	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—APP—Alzheimer's disease	3.57e-05	0.000444	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL2—Alzheimer's disease	3.52e-05	0.000438	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOS3—Alzheimer's disease	3.46e-05	0.00043	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PSENEN—Alzheimer's disease	3.45e-05	0.00043	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APH1A—Alzheimer's disease	3.41e-05	0.000424	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PLCB1—Alzheimer's disease	3.37e-05	0.000419	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NCSTN—Alzheimer's disease	3.32e-05	0.000413	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LRP1—Alzheimer's disease	3.23e-05	0.000402	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	3.22e-05	0.000401	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.18e-05	0.000395	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GAL—Alzheimer's disease	3.16e-05	0.000393	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GFAP—Alzheimer's disease	3.16e-05	0.000393	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	3.12e-05	0.000388	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	3.01e-05	0.000375	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—Alzheimer's disease	2.96e-05	0.000369	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.95e-05	0.000367	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—Alzheimer's disease	2.94e-05	0.000365	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—Alzheimer's disease	2.92e-05	0.000363	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	2.88e-05	0.000359	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	2.87e-05	0.000357	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	2.85e-05	0.000355	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—A2M—Alzheimer's disease	2.78e-05	0.000346	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	2.77e-05	0.000345	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	2.77e-05	0.000345	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.74e-05	0.000342	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	2.73e-05	0.00034	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK8—Alzheimer's disease	2.7e-05	0.000336	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PSEN2—Alzheimer's disease	2.7e-05	0.000336	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—Alzheimer's disease	2.69e-05	0.000335	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	2.68e-05	0.000333	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	2.63e-05	0.000327	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	2.61e-05	0.000325	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR5—Alzheimer's disease	2.6e-05	0.000324	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	2.58e-05	0.000321	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	2.58e-05	0.000321	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	2.51e-05	0.000312	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SST—Alzheimer's disease	2.51e-05	0.000312	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	2.51e-05	0.000312	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	2.5e-05	0.000311	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKCG—Alzheimer's disease	2.49e-05	0.00031	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—Alzheimer's disease	2.49e-05	0.00031	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	2.48e-05	0.000309	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NPY—Alzheimer's disease	2.48e-05	0.000309	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IAPP—Alzheimer's disease	2.47e-05	0.000307	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APP—Alzheimer's disease	2.44e-05	0.000304	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CRH—Alzheimer's disease	2.39e-05	0.000298	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR5—Alzheimer's disease	2.36e-05	0.000294	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	2.35e-05	0.000292	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	2.3e-05	0.000287	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—Alzheimer's disease	2.29e-05	0.000285	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NPS—Alzheimer's disease	2.27e-05	0.000282	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PPP3CA—Alzheimer's disease	2.26e-05	0.000281	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—F2—Alzheimer's disease	2.23e-05	0.000278	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTK2B—Alzheimer's disease	2.23e-05	0.000277	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SST—Alzheimer's disease	2.17e-05	0.000269	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NTRK2—Alzheimer's disease	2.17e-05	0.000269	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GAB2—Alzheimer's disease	2.17e-05	0.000269	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CALM1—Alzheimer's disease	2.16e-05	0.000268	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	2.15e-05	0.000268	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GSK3A—Alzheimer's disease	2.15e-05	0.000267	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	2.14e-05	0.000266	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APP—Alzheimer's disease	2.11e-05	0.000263	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	2.1e-05	0.000261	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	2.09e-05	0.00026	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	2.03e-05	0.000252	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.99e-05	0.000248	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	1.99e-05	0.000247	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	1.89e-05	0.000235	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—Alzheimer's disease	1.88e-05	0.000234	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	1.86e-05	0.000231	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.85e-05	0.00023	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.83e-05	0.000227	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.81e-05	0.000226	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.81e-05	0.000225	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	1.75e-05	0.000218	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.74e-05	0.000216	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—Alzheimer's disease	1.72e-05	0.000214	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	1.72e-05	0.000213	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.7e-05	0.000212	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	1.66e-05	0.000207	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	1.63e-05	0.000203	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	1.61e-05	0.000201	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—Alzheimer's disease	1.59e-05	0.000198	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	1.58e-05	0.000197	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.58e-05	0.000197	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	1.51e-05	0.000188	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	1.5e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	1.47e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	1.47e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	1.47e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	1.47e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	1.46e-05	0.000181	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	1.43e-05	0.000178	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	1.4e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	1.4e-05	0.000174	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—F2—Alzheimer's disease	1.39e-05	0.000172	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.36e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	1.27e-05	0.000158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.27e-05	0.000158	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	1.27e-05	0.000158	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	1.27e-05	0.000158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	1.26e-05	0.000157	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	1.26e-05	0.000156	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INS—Alzheimer's disease	1.26e-05	0.000156	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	1.23e-05	0.000154	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	1.21e-05	0.000151	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	1.21e-05	0.000151	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—F2—Alzheimer's disease	1.2e-05	0.000149	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.17e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.1e-05	0.000137	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.1e-05	0.000137	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.09e-05	0.000136	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.08e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.07e-05	0.000133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.05e-05	0.000131	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	9.51e-06	0.000118	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	9.43e-06	0.000117	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	9.34e-06	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	9.28e-06	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	8.59e-06	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	8.57e-06	0.000107	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	8.15e-06	0.000101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	8.07e-06	0.0001	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	8.02e-06	9.98e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	7.93e-06	9.87e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	7.42e-06	9.23e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	7.4e-06	9.21e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	7.28e-06	9.06e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	6.85e-06	8.52e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	6.29e-06	7.82e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	5.99e-06	7.46e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	5.48e-06	6.82e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	5.18e-06	6.44e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	5.06e-06	6.3e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	4.74e-06	5.9e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	4.37e-06	5.44e-05	CbGpPWpGaD
